Status:

COMPLETED

Effects of Cigarette and E-cigarette Flavors on Substitutability in the ETM

Lead Sponsor:

Virginia Polytechnic Institute and State University

Collaborating Sponsors:

National Cancer Institute (NCI)

Medical University of South Carolina

Conditions:

Cigarette Smoking Behavior

Eligibility:

All Genders

21-65 years

Phase:

NA

Brief Summary

In 2009, the FDA banned all flavored conventional cigarettes except menthol. While no such ban exists for e-cigarettes, proposals have emerged in several regions. Flavors are key targets for tobacco c...

Detailed Description

This study does not involve any smoking cessation interventions. This study does involve experimental manipulation of nicotine/tobacco product price and availability to understand consumers' behavior....

Eligibility Criteria

Inclusion

  • Be between 21 and 65 years of age
  • Cigarette smokers
  • Smoke cigarettes daily (≥ 5 cigarettes/day)
  • Do not use e-cigarettes regularly (no more than 9 times in the last month)
  • Be willing to try e-cigarettes

Exclusion

  • Pregnant or lactating women
  • Plans to move out of the area
  • Use of prescription medication that might affect smoking or nicotine metabolism
  • Unmanaged medical or psychiatric conditions
  • Plans to quit smoking within the next 30 days
  • This study will focus on cigarette smokers and dual users. We will not include individuals under the age of 21 in compliance with Virginia state law. Minors, pregnant women, prisoners, and adults not capable to consent on their own behalf will be excluded from this study.
  • Minors, as defined by state law where the study is performed (infants, children, teenagers)
  • Pregnant women (can be included in minimal risk studies by mentioning in section 13.1)
  • Prisoners (including all incarcerated individuals)
  • Adults not capable to consent on their own behalf

Key Trial Info

Start Date :

July 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 25 2022

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT06910202

Start Date

July 8 2021

End Date

May 25 2022

Last Update

December 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, United States, 24016